Niaspan and simvastatin are two prescribed medicines for treating cholesterol widely. Niaspan is utilized to raise HDL ‘good’ cholesterol levels, and simvastatin is effective in reducing LDL ‘poor’ cholesterol levels. This combination has been submitted for FDA authorization to address LDL, HDL and triglycerides within a pill, which may lead to improved patient convenience and outcomes. The Niaspan/simvastatin application contains data from two large clinical studies, made up of more than 1,150 randomized patients, which evaluated safety and efficacy of the combination of Niaspan and simvastatin in patients with mixed dyslipidemia.There was your final follow-up visit at week 26 also. Related StoriesStudy explores diabetes screening for sufferers with serious mental illnessWeight-loss surgery may be safe for managing type 2 diabetes in individuals with moderate obesityNew Cleveland Clinic study shows bariatric surgery is safe choice for managing type 2 diabetes in obese or mildly obese patientsThe proportion of sufferers attending these appointments declined over the study period, from 91 percent at week 6 to 80 percent at week 18, and the proportion doing this within 7 days of the planned time fell from 86 percent to 71 percent.